Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Purlytin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BackgroundPhotodynamic therapy (PDT) is photo-treatment of malignant or benign diseases using photosensitizing agents, light, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Review
2009
Review
2009
Photodynamic therapy (PDT) is now a well-recognized modality for the treatment of cancer. While PDT has developed progressively… Expand
  • figure 1
  • table 4
  • table 3
  • figure 2
  • figure 3
Is this relevant?
Review
2004
Review
2004
  • Drugs in R&D
  • 2004
  • Corpus ID: 43023466
The photosensitiser rostaporfin [Purlytin trade mark, SnET2, tin ethyl etiopurpurin, Sn(IV) etiopurpurin, PhotoPoint SnET2] was… Expand
Is this relevant?
Review
2002
Review
2002
Pharmacia Corp, under license from Miravant Medical Technologies (formerly PDT Inc), is developing rostaporfin (SnET2, Purlytin… Expand
Is this relevant?
Review
2002
Review
2002
Purpose To review the biophysical basis and current state of therapy for photodynamic closure of subfoveal choroidal… Expand
Is this relevant?
Review
2002
Review
2002
  • David W. C. Hunt
  • IDrugs : the investigational drugs journal
  • 2002
  • Corpus ID: 9152145
Pharmacia Corp, under license from Miravant Medical Technologies (formerly PDT Inc), is developing rostaporfin (SnET2, Purlytin… Expand
Is this relevant?
1999
1999
We are investigating the use of Scanning Doppler Velocimetry to evaluate changes in tissue perfusion that occur during… Expand
Is this relevant?
1998
1998
BACKGROUND Chest wall recurrence of breast cancer after mastectomy, radiation therapy, and chemotherapy poses a therapeutic… Expand
Is this relevant?
1998
1998
BACKGROUND AND OBJECTIVES Photodynamic therapy (PDT) using a photoreactive purpurin, tin ethyl etiopurpurin (SnET2, Purlytin… Expand
Is this relevant?